R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome

被引：5
|
作者：
Martin, Alejandro [1 ]
Caballero, Maria-Dolores [2 ]
机构：
[1] Complejo Hosp Zamora, Dept Hematol, Zamora 49022, Spain
[2] Hosp Univ Salamanca, Dept Hematol, Salamanca, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷 / 05期
关键词：
RITUXIMAB;
D O I：
10.3324/haematol.2009.006452
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：744 / 744
页数：1
相关论文
共 50 条
  • [41] Role of Consolidative Radiation Therapy Following Autologous Stem Cell Transplant for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Coutu, B. G.
    Wilke, C. T.
    Yuan, J.
    Cao, Q.
    Vernon, M. R.
    Lee, C. K.
    Dusenbery, K. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S66 - S66
  • [42] SALVAGE TREATMENT WITH R-IEV (RITUXIMAB, IFOSFAMIDE, EPIRUBICIN, ETOPOSIDE) AND AUTOLOGOUS STEM CELL TRANSPLANT FOR RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
    Gumenyuk, S.
    Marchesi, F.
    Borza, P. Anticoli
    Renzi, D.
    Palombi, F.
    Pisani, F.
    Romano, A.
    Spadea, A.
    Canfora, M.
    Papa, E.
    Mengarelli, A.
    HAEMATOLOGICA, 2016, 101 : 685 - 686
  • [43] Outcome in Unselected Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Following R-CHOP When Stem Cell Transplantation Is Not Feasible
    Kansara, Roopesh R.
    Savage, Kerry J.
    Villa, Diego
    Shenkier, Tamara
    Gerrie, Alina S.
    Klasa, Richard
    Hitz, Felicitas
    Scott, David W.
    Slack, Graham W.
    Gascoyne, Randy D.
    Connors, Joseph M.
    Sehn, Laurie H.
    BLOOD, 2014, 124 (21)
  • [44] Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma
    Tanimoto, Tetsuya
    Oshima, Kumi
    Tsuda, Kenji
    Mori, Jinichi
    Shimmura, Hiroaki
    LANCET ONCOLOGY, 2017, 18 (10): : E557 - E557
  • [45] Outcomes of salvage chemotherapy and autologous stem cell transplantation for relapsed or refractory primary mediastinal large B cell lymphoma (PMLCL) are inferior to diffuse large B cell lymphoma (DLBCL).
    Kuruvilla, J
    Nagy, T
    Pintilie, M
    Keating, A
    Crump, M
    BLOOD, 2005, 106 (11) : 590A - 590A
  • [46] Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation
    Cazelles, Clarisse
    Belhadj, Karim
    Vellemans, Helene
    Camus, Vincent
    Poullot, Elsa
    Gaulard, Philippe
    Veresezan, Liana
    Itti, Emmanuel
    Becker, Stephanie
    Carvalho, Muriel
    Dupuis, Jehan
    Le Bras, Fabien
    Lemonnier, Francois
    Roulin, Louise
    El Gnaoui, Taoufik
    Jardin, Fabrice
    Mounier, Nicolas
    Tilly, Herve
    Haioun, Corinne
    LEUKEMIA & LYMPHOMA, 2021, 62 (09) : 2161 - 2168
  • [47] Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma
    Hamlin, PA
    Zelenetz, AD
    Kewalramani, T
    Qin, J
    Satagopan, JM
    Verbel, D
    Noy, A
    Portlock, CS
    Straus, DJ
    Yahalom, J
    Nimer, SD
    Moskowitz, CH
    BLOOD, 2003, 102 (06) : 1989 - 1996
  • [48] ESHAP Versus Rituximab-ESHAP in Frail Patients With Refractory Diffuse Large B-Cell Lymphoma
    Aviles, Agustin
    Neri, Natividad
    Huerta-Guzman, Judith
    de Jesus Nambo, Maria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (02): : 125 - 128
  • [49] Impact of time to relapse and response to salvage therapy on post autologous stem cell transplant outcomes in relapsed or refractory diffuse large B-cell lymphoma.
    Tun, Aung M.
    Wang, Yucai
    Maliske, Seth
    Farooq, Umar
    Micallef, Ivana N. M.
    Inwards, David James
    Porrata, Luis F.
    Ansell, Stephen M.
    Rosenthal, Allison Claire
    Kharfan-Dabaja, Mohamed
    Link, Brian K.
    Villasboas, Jose Caetano
    Paludo, Jonas
    Cerhan, James Robert
    Habermann, Thomas Matthew
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    Johnston, Patrick B.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
    Kewalramani, T
    Zelenetz, AD
    Nimer, SD
    Portlock, C
    Straus, D
    Noy, A
    O'Connor, O
    Filippa, DA
    Teruya-Feldstein, J
    Gencarelli, A
    Qin, J
    Waxman, A
    Yahalom, J
    Moskowitz, CH
    BLOOD, 2004, 103 (10) : 3684 - 3688
12345